BioSpace News Archive

The POLARSTEM/R3 combination demonstrated the highest survivorship of any stem/cup combination regardless of fixation method at seven years

Multiple audio wellness programs available exclusively for Audible members New collaboration highlights growing consumer demand for unique audio content across the wellness aspect of listeners’ lives

Recent randomized studies with existing IVUS systems have shown that intravascular imaging has the potential to significantly improve clinical outcomes during angioplasty and stenting.

Landmark legislation was introduced in the U.S. Senate today to help reduce veteran suicides and improve mental health outcomes by implementing changes at the U.S. Department of Veteran Affairs (VA) to increase access to mental health care, expand diagnostic research and authorize new programs to combat veteran suicides.

Conference call scheduled for 4:30 p.m. ET today

Cell and gene therapy has the potential to transform medicine, providing long-term and potentially curative treatment options for a wide range of diseases.

Boston Scientific Corporation (NYSE: BSX) announced it has received CE Mark and initiated a limited market release of the next generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device in Europe.

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. based pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China, U.S., and throughout the world, announced that the Company has entered into an exclusive distribution agreement

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol, an oral therapy for the treatment of nonalcoholic steatohepatitis, or NASH, today reported financial results for the three and twelve months ended December 31, 2018.

Westleaf Inc. (TSX-V: WL) (“Westleaf”), is pleased to announce the Town of Banff has approved its development permit for a flagship retail location in the heart of Canada’s most visited national park.